Funding News

Ultrahuman Raises $70 Million Led by Qualcomm Ventures — India's Bengaluru Smart Ring Company Is Becoming a Human-Computer Interface Platform

By Mustafa Shariff, Editor in Chief · September 10,2026 · 2 mins read

Mustafa Shariff, Editor in Chief — Ultrahuman Raises $70 Million Led by Qualcomm Ventures — India's Bengaluru Smart Ring Company Is Becoming a Human-Computer Interface Platform

Summary

  • Ultrahuman Raises $70M Led by Qualcomm Ventures: Bengaluru's Smart Ring Company Becomes Human-Computer Interface Platform at $365M Valuation
  • Ultrahuman raised $70M ($65M equity + $5M debt) led by Qualcomm Ventures with Labcorp, Alpha Wave, Blume, Nexus, Alteria — valuing the Bengaluru health intelligence company at $365M (~3x from 2023). Revenue Rs 565 crore, profitable in FY25.

"For the longest time, computers have understood almost everything about the world except the person using them. We want to change that. We are building an interface that can understand the body continuously and translate its signals into intelligence that is useful in everyday life. The Ultrahuman Ring was the beginning. The $70 million we have raised is the fuel for what comes next — integrating Qualcomm's compute architecture into our hardware, expanding our clinical metabolic research workforce, and scaling across India and globally."

Ultrahuman — the Bengaluru-based health intelligence company known for its Ultrahuman Ring smart rings, M1/M2 continuous glucose monitoring devices, and Blood Vision blood testing platform — announced the close of a $70 million funding round on September 3, 2026. The round comprises $65 million in primary equity and $5 million in debt, values the company at $365 million post-money (approximately three times its $120 million valuation from a prior raise in 2023), and is led by Qualcomm Ventures, with Labcorp, Alpha Wave, Blume Ventures, Nexus Venture Partners, and Alteria Capital as co-investors.
Why Qualcomm and Labcorp Are the Most Meaningful Investors
The composition of Ultrahuman's investor base is as significant as the amount raised. Qualcomm Ventures — the investment arm of the semiconductor company that makes the chips powering smartphones, smart wearables, and AI edge computing devices — is investing with the explicit intent of integrating Qualcomm microchips into Ultrahuman's wearable hardware architecture. This transforms the investment from pure capital into a strategic technology partnership: Qualcomm's chip architecture provides the computational power for Ultrahuman to run increasingly sophisticated AI algorithms at the device level rather than cloud-dependent processing. Labcorp — the US-based diagnostics giant — brings clinical validation credibility: a major diagnostics company co-investing signals that Ultrahuman's health data aspirations are clinically relevant, not merely consumer wellness.
The Platform: From Ring to Human-Computer Interface
Ultrahuman launched in 2018 with the Ultrahuman Ring — a finger-worn device tracking sleep quality, heart rate variability, recovery scores, and activity. The company has since expanded into continuous glucose monitoring (M1/M2), blood testing (Blood Vision), environmental sensing (Ultrahuman Home), AI integration (Jade), and large-scale health research (Pulsomics — an opt-in platform launched in 2026 allowing Ring users to participate in real-world longitudinal health studies).
Mohit Kumar, co-founder and CEO, is positioning the company's next phase around 'human-computer interface' — a platform that can continuously understand signals from the body (physiological, biochemical, environmental, contextual) and translate them into actionable health intelligence. The $70 million will fund: Qualcomm chip integration into wearable hardware, expansion of clinical metabolic research workforce, scaling of global offline retail, and market expansion in India and the UAE.
The Commercial Metrics
Ultrahuman reported revenue of Rs 565 crore and profit after tax of Rs 73 crore in FY25 — profitable before raising this $70 million round. Revenue for FY26 is projected significantly higher. This profitability-before-large-raise profile is uncommon in India's healthtech sector and signals that the business model is commercially validated rather than growth-at-any-cost.
BHC Perspective
At Bengaluru Health Community, Ultrahuman's $70 million round led by Qualcomm Ventures is the most significant Bengaluru healthtech funding event of 2026 — and the one with the deepest technology depth. For BHC founders in digital health, health wearables, or AI-powered health analytics — Ultrahuman's trajectory from consumer wellness ring to clinical-grade, Qualcomm-integrated human-computer interface platform is the commercial destination that India's health technology sector is capable of reaching.
Frequently Asked Questions
Q: What did Ultrahuman raise?
A: $70 million ($65M equity + $5M debt) at $365M post-money valuation (~3x from 2023). Led by Qualcomm Ventures. Co-investors: Labcorp, Alpha Wave, Blume Ventures, Nexus Venture Partners, Alteria Capital. Announced September 3, 2026.
Q: Why is Qualcomm Ventures leading strategically significant?
A: Qualcomm makes the chips powering smart wearables and AI edge devices. Its lead investment signals explicit Qualcomm chip integration into Ultrahuman's hardware — enabling on-device AI processing rather than cloud dependence. Labcorp's co-investment signals clinical diagnostics relevance, not just consumer wellness.
Q: What are Ultrahuman's commercial metrics?
A: FY25 revenue: Rs 565 crore. FY25 PAT: Rs 73 crore (profitable). Products: Ring AIR, Ring PRO, M1/M2 CGM, Blood Vision blood testing, Ultrahuman Home, Jade AI, Pulsomics research platform. Founded by Mohit Kumar and Vatsal Singhal. Bengaluru headquarters.